Last reviewed · How we verify

TRYPAN BLUE

FDA-approved approved Small molecule Quality 14/100

MembraneBlue 0.15% selectively stains membranes in the human eye during posterior surgery.

At a glance

Generic nameTRYPAN BLUE
ModalitySmall molecule
PhaseFDA-approved
First approval2004

Mechanism of action

MembraneBlue 0.15% is used to stain specific membranes in the eye, such as epiretinal membranes (ERM) and Internal Limiting Membranes (ILM), making them more visible during surgical procedures.

Approved indications

No approved indications tracked.

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: